GT Biopharma, Inc.GTBPNASDAQ
Loading
SG&A Expenses Over TimeContracting
Percentile Rank64
3Y CAGR-10.4%
5Y CAGR+7.3%
Year-over-Year Change
Selling, general, and administrative expenses
3Y CAGR
-10.4%/yr
vs -0.1%/yr prior
5Y CAGR
+7.3%/yr
Recent deceleration
Acceleration
-10.3pp
Decelerating
Percentile
P64
Within normal range
vs 5Y Ago
1.4x
Solid growth
Streak
2 yr
Consecutive growthContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $8.95M | +4.5% |
| 2024 | $8.57M | +20.5% |
| 2023 | $7.11M | -42.9% |
| 2022 | $12.45M | -74.0% |
| 2021 | $47.92M | +663.2% |
| 2020 | $6.28M | -35.8% |
| 2019 | $9.79M | -21.6% |
| 2018 | $12.49M | -90.7% |
| 2017 | $134.50M | +1501.4% |
| 2016 | $8.40M | - |